Cryotherapy Market

North America and APAC regions to promote the all-round development of the global cryotherapy market in the next 10 years

The global market for cryotherapy is highly fragmented with major players following prevailing trends of partnerships and associations to provide long-term best-in-quality services. Companies are rapidly collaborating with sports clubs, athletics organizations, and other complementary business providers to continue their organic business growth. For example, Impact Cryotherapy – a leading cryosaunas manufacturer and seller based in the U.S. – signed several pacts with multiple sports associations.

Leading market players are in stiff competition to hold the maximum share of the global cryotherapy market. Some of the big names in the global cryotherapy market are expanding their portfolio of products to offer new or technologically advanced products to their targeted consumers. In May 2015, Erbe Elektromedizin GmbH launched ERBECRYO 2 Cryosurgical Unit for use in plastic surgery, which comes with a flexible cryoprobe to avoid destruction of surrounding tissue.

North America region anticipated to dominate the global cryotherapy market during the forecast period

The global cryotherapy market revenue is expected to increase at a CAGR of 6.5% over the forecast period (2016–2024). The North America cryotherapy market occupied more than 35% revenue share in 2015. An increasing number of surgical procedures in the region, rapid product launches and expansion of product indication are the primary factors driving the growth of the cryotherapy market in North America. This region is expected to be the fastest growing market for cryotherapy primarily due to the entry of major market players and emerging local players.

Despite the fact that cryotherapy has been prevalent in North America for several years, expansion of product indications for aesthetic workstation as well as medical purposes is expected to create a driving force for the growth of the cryotherapy market in the region. Within the forecast period, APAC region is likely to retain the third position in the global cryotherapy market. Growing installed base of cryosurgical equipment and cryochambers in countries such as China, Japan and Australia will fuel this regional market.

Comparative Study of North America and APAC cryotherapy markets

APAC is expected to represent an incremental opportunity of more than US$ 200 Mn between 2015 and 2024 and is projected to contribute more than 15% to total incremental opportunity. The market is likely to grow between US$ 20 Mn to US$ 45 Mn annually over 2016-2024. The U.S will play a significant role in the expansion of the North America cryotherapy market. The U.S market is projected to cross a market valuation of US$ 1500 Mn by the end of 2024, registering a CAGR of 7.8% through the forecast period.

The Canada cryotherapy market is expected to grow at a CAGR of 5.1% over the forecast period. Cryotherapy (except cryosurgery) is not readily adopted in Canada, leading to a sluggish growth of the cryotherapy market in Canada. Cryosurgery is preferred by most of the office based gynecologists in the U.S due to its efficiency to treat cancer lesions and prevent the recurrence of cancer lesions. Availability of skilled doctors and the necessary technology in hospitals makes it the most lucrative end user segment in the North America cryotherapy market.

In the APAC region, Japan was expected to hold more than 25% of the global market share till the end of 2016 and is expected to lose more than 70 basis points by 2024. The China cryotherapy market is expected to expand at a CAGR of 8.1% over the forecast period. The market in China is dominated by a number of local players such as Guangzhou XZ Beauty Machine Co. Ltd. and SUS Advancing Technology Co. Limited. However, gradual entry of larger international companies such as Zimmer Medizinsysteme GmbH is expected to drive revenue growth of the China market.

The cryotherapy market in India is estimated to gain more than 15 basis points by 2024. The Australia & New Zealand cryotherapy market is estimated to represent an incremental opportunity of more than US$ 40 Mn between 2016 and 2024. The increasing application of cryosurgery for the treatment of prostate cancer and inbound medical tourism for cryosurgery in Australia are likely to boost the growth of the cryotherapy market in the country.

Global Cryotherapy Market Segmentation

To know more about delivery timeline for this report Contact Sales